MiR-493-5p inhibits Th9 cell differentiation in allergic asthma by targeting FOXO1

Xingyu Rao,Heting Dong,Weili Zhang,Huiming Sun,Wenjing Gu,Xinxing Zhang,Li Huang,Yongdong Yan,Chuangli Hao,Wei Ji,Canhong Zhu,Zhengrong Chen
DOI: https://doi.org/10.1186/s12931-022-02207-2
IF: 5.8
2022-10-18
Respiratory Research
Abstract:The role of micro RNAs (miRNAs) in asthma remains unclear. In this study, we examined the role of miRNA in targeting FOXO1 in asthma. Results showed that miR-493-5p was one of the differentially expressed miRNAs in the PBMCs of asthmatic children, and was also associated with Th cell differentiation. The miR-493-5p expression decreased significantly in the OVA-induced asthma mice than the control groups. The miR-493-5p mimic inhibited the expression of the IL-9, IRF4 and FOXO1, while the inhibitor restored these effects. Moreover, the Dual-Luciferase analysis results showed FOXO1 as a novel valid target of miR-493-5p. According to the rescue experiment, miR-493-5p inhibited Th9 cell differentiation by targeting FOXO1. Then the exosomes in association with the pathogenesis of asthma was identified. Various inflammatory cells implicated in asthmatic processes including B and T lymphocytes, DCs, mast cells, and epithelial cells can release exosomes. Our results demonstrated that the DC-derived exosomes can inhibit Th9 cell differentiation through miR-493-5p, thus DC-derived exosomal miR-493-5p/FOXO1/Th9 may serve as a potential therapeutic target in the development of asthma.
respiratory system
What problem does this paper attempt to address?